HGF from the metastatic liver microenvironment was shown to activate the c-Met/PI3K/AKT/mTOR axis in CRC cells, activating the SREBP2-dependent cholesterol biosynthesis pathway to promote CRC liver metastasis [68]. The gene discussed is SREBF2; the disease is colorectal carcinoma.